More than 17 million people have been prescribed Lipitor, according to its manufacturer Pfizer. Last year, Lipitor’s sale added up to more than $5 billion in the United States alone, according to Medco.

While it is not known how much cheaper the generic version of the cholesterol-lowering drug will be, Pfizer is working with pharmacy benefit companies to lower co-payments to hold on to as many customers as possible.